Literature DB >> 15193744

Oleamide and anandamide effects on food intake and sexual behavior of rats.

Dolores Martínez-González1, Herlinda Bonilla-Jaime, Adriana Morales-Otal, Steven J Henriksen, Javier Velázquez-Moctezuma, Oscar Prospéro-García.   

Abstract

Oleamide is a lipid with diverse properties, including cannabinoid-like activity. For example, it induces the classic triad of effects attributable to these molecules: decrease in core temperature, hypolocomotion, and reduction in pain perception. However, as it binds to the cannabinoid receptors (CB1) only at high concentrations, it is not considered an actual endocannabinoid. In this study, we tested the effect of oleamide on food intake and sexual behavior and compared it to the effect induced by anandamide. Results indicate that oleamide and anandamide increased food intake during the 3h post-injection. In addition, anandamide but not oleamide induced changes in sexual performance. This study further supports the role of endocannabinoids in food ingestion and male sexual behavior and gives additional support to the notion that, although oleamide might not be an endocannabinoid, it shares some effects with them. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193744     DOI: 10.1016/j.neulet.2004.03.080

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  The endocannabinoid system modulates the valence of the emotion associated to food ingestion.

Authors:  Mónica Méndez-Díaz; Pavel Ernesto Rueda-Orozco; Alejandra Evelyn Ruiz-Contreras; Oscar Prospéro-García
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

2.  Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes.

Authors:  Régis Roche; Laurence Hoareau; Sandrine Bes-Houtmann; Marie-Paule Gonthier; Christine Laborde; Jean-François Baron; Yacine Haffaf; Maya Cesari; Franck Festy
Journal:  Histochem Cell Biol       Date:  2006-01-04       Impact factor: 4.304

Review 3.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

Review 4.  The expanding field of cannabimimetic and related lipid mediators.

Authors:  Heather B Bradshaw; J Michael Walker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

5.  Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors.

Authors:  Ana Canseco-Alba; Gabriela Rodríguez-Manzo
Journal:  Psychopharmacology (Berl)       Date:  2014-03-27       Impact factor: 4.530

6.  Primary fatty acid amide metabolism: conversion of fatty acids and an ethanolamine in N18TG2 and SCP cells.

Authors:  Emma K Farrell; Yuden Chen; Muna Barazanji; Kristen A Jeffries; Felipe Cameroamortegui; David J Merkler
Journal:  J Lipid Res       Date:  2011-11-16       Impact factor: 5.922

Review 7.  Cannabinoids in eating disorders and obesity.

Authors:  Francisco Arias Horcajadas
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

8.  A potential function of endocannabinoids in the selection of a navigation strategy by rats.

Authors:  Pavel E Rueda-Orozco; Edgar Soria-Gomez; Corinne J Montes-Rodriguez; Marina Martínez-Vargas; Oscar Galicia; Luz Navarro; Oscar Prospero-García
Journal:  Psychopharmacology (Berl)       Date:  2007-09-06       Impact factor: 4.530

9.  Endocannabinoid modulation of male rat sexual behavior.

Authors:  Boris B Gorzalka; Anna C Morrish; Matthew N Hill
Journal:  Psychopharmacology (Berl)       Date:  2007-08-13       Impact factor: 4.530

10.  Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.

Authors:  E Soria-Gómez; I Matias; P E Rueda-Orozco; M Cisneros; S Petrosino; L Navarro; V Di Marzo; O Prospéro-García
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.